Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 3/20 | 0.64 |
| ▸ | ATM | Q13315 | 1/20 | 0.60 |
| ▸ | NAAA | Q02083 | 1/20 | 0.48 |
| ▸ | APP | P05067 | 4/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.47 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.46 |
| ▸ | PRKCA | P17252 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8380051 | 1.00 | HCAR2 (0.64) | HCAR2ATMNAAAAPPTSHR | |
| SCHEMBL35541 | 1.00 | HCAR2 (0.64) | HCAR2ATMNAAAAPPTSHR | |
| SCHEMBL1452757 | 1.00 | HCAR2 (0.64) | HCAR2ATMNAAAAPPTSHR | |
| SCHEMBL3457992 | 1.00 | HCAR2 (0.64) | HCAR2ATMNAAAAPPTSHR | |
| SCHEMBL29341 | 1.00 | HCAR2 (0.64) | HCAR2ATMNAAAAPPTSHR | |
| SCHEMBL15229292 | 1.00 | HCAR2 (0.64) | HCAR2ATMNAAAAPPTSHR | |
| SCHEMBL2906298 | 1.00 | HCAR2 (0.64) | HCAR2ATMNAAAAPPTSHR | |
| SCHEMBL2903635 | 1.00 | HCAR2 (0.64) | HCAR2ATMNAAAAPPTSHR | |
| SCHEMBL19579380 | 0.98 | ATM (0.63) | HCAR2ATMNAAAAPPTSHR | |
| SCHEMBL6465406 | 0.98 | ATM (0.63) | HCAR2ATMNAAAAPPTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1835 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747302-A2 | REPAIR AND OPTIMIZATION OF NANOCOMPOSITE MATERIALS | Nanocore ApS (DK) | 2026-05-27 | — | — | EP | claimed |
| CN-122070874-A | Preparation method of ultrathin elastic bioelectrode based on liquid metal | 中国科学院宁波材料技术与工程研究所 | 2026-05-22 | — | — | CN | claimed |
| EP-4717744-A1 | USE OF A COMPOSITION BASED ON CYANOACRYLATE AND (METH)ACRYLATE | Bostik SA (FR) | 2026-04-01 | — | — | EP | claimed |
| EP-4712923-A1 | WOUND CLOSURE SYSTEM, KITS AND METHOD | Davenport, Thomas A. (US) | 2026-03-25 | — | — | EP | claimed |
| EP-4701481-A1 | APPARATUS AND METHOD FOR LIFTING AND TIGHTENING SKIN OF THE FACE | Daniel Cyr M.D. Inc. (CA) | 2026-03-04 | — | — | EP | claimed |
| EP-3852815-B1 | STABLE COMPOSITIONS COMPOSED OF A RADIOPAQUE AGENT AND CYANOACRYLATE MONOMER AND APPLICATIONS THEREOF | CHEMENCE MEDICAL INC (US) | 2026-02-25 | — | — | EP | claimed |
| US-20260041183-A1 | ADHESIVE FOR COSMETIC ARTICLE AND METHOD OF FORMING | FULLER H B CO (US) | 2026-02-12 | — | — | US | claimed |
| US-12514874-B2 | Antiseptic applications of metal nanoparticle agglomerates | KUPRION INC. (US) | 2026-01-06 | — | — | US | claimed |
| WO-2025242824-A1 | PART FOR COVERING A BONE DEFECT | GLAD MEDICAL (FR) | 2025-11-27 | — | — | WO | claimed |
| EP-4127003-B1 | HYBRID LIGHT-CURING COMPOSITION | DYMAX CORP (US) | 2025-11-12 | — | — | EP | claimed |
| EP-0824353-A1 | METHODS TO INHIBIT ACUTE RADIATION-INDUCED SKIN DAMAGE | MedLogic Global Corporation (US) | 1998-02-25 | — | — | EP | claimed |
| US-5716607-A | PREAPPLYING A LAYER OF BIOCOMPATIBLE POLYMER | MEDLOGIC GLOBAL CORPORATION (US) | 1998-02-10 | — | — | US | claimed |
| US-5575997-A | CYANTOACRYLATES | TRI-POINT MEDICAL CORPORATION (US) | 1996-11-19 | — | — | US | claimed |
| WO-1996034610-A1 | METHODS TO INHIBIT ACUTE RADIATION-INDUCED SKIN DAMAGE | MEDLOGIC GLOBAL CORPORATION (US) | 1996-11-07 | — | — | WO | claimed |
| WO-1996034611-A1 | METHODS TO INHIBIT LATE RADIATION-INDUCED SKIN DAMAGE | MEDLOGIC GLOBAL CORPORATION (US) | 1996-11-07 | — | — | WO | claimed |
| US-5554365-A | Use of cyanoacrylate adhesive compositions to inhibit acute radiation-induced skin damage | MEDLOGIC GLOBAL CORPORATION (US) | 1996-09-10 | — | — | US | claimed |
| US-5514372-A | Biocompatible monomer and formaldehyde producing polymer compositions | TRI-POINT MEDICAL L.P. (US) | 1996-05-07 | — | — | US | claimed |
| US-5514371-A | CYANOACRYLATES | TRI-POINT MEDICAL L.P. (US) | 1996-05-07 | — | — | US | claimed |
| EP-0617973-A1 | Biocompatible monomer and polymer compositions | TRI-POINT MEDICAL CORPORATION (US) | 1994-10-05 | — | — | EP | claimed |
| US-5328687-A | Cyanoacrylate tissue adhesives, formaldehyde scavenger | TRI-POINT MEDICAL L.P. (US) | 1994-07-12 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260041183-A1 | ADHESIVE FOR COSMETIC ARTICLE AND METHOD OF FORMING | KRT18, CDH1, CFL1 | HCAR2 3987/4885ATM 2463/4885NAAA 2705/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.